Diffusion-weighted MR imaging in the head and neck

Radiology

Volumn 263, Issue 1, 2012, Pages 19-32

  Thoeny, Harriet C ^a   De Keyzer, Frederik ^b   King, Ann D ^c  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

APPARENT DIFFUSION COEFFICIENT; ARTIFACT REDUCTION; CANCER STAGING; CHOLESTEATOMA; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HEAD AND NECK TUMOR; HUMAN; IMAGE ANALYSIS; LYMPH NODE METASTASIS; LYMPHOMA; NONHUMAN; PATIENT MONITORING; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RADIOLOGICAL PARAMETERS; REVIEW; SALIVARY GLAND FUNCTION; SALIVARY GLAND TUMOR; THYROID FUNCTION; THYROID TUMOR; TISSUE CHARACTERIZATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR RECURRENCE; ARTIFACT; COMPUTER ASSISTED DIAGNOSIS; METHODOLOGY; PATHOLOGY; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY;

CONTRAST MEDIUM; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ARTIFACTS; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; HEAD AND NECK NEOPLASMS; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LYMPHATIC METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY;

EID: 84861325034     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.11101821     Document Type: Review

References (69)

1. Schaefer PW, Grant PE, Gonzalez RG. Diffusion-weighted MR imaging of the brain. Radiology 2000;217(2):331-345.
2. Buckley BT, Wainwright A, Meagher T, Briley D. Audit of a policy of magnetic resonance imaging with diffusion-weighted imaging as first-line neuroimaging for in-patients with clinically suspected acute stroke. Clin Radiol 2003;58(3):234-237. (Pubitemid 36335949)
3. Thoeny HC, De Keyzer F. Extracranial applications of diffusion-weighted magnetic resonance imaging. Eur Radiol 2007;17(6):1385-1393. (Pubitemid 46767586)
4. Moffat BA, Chenevert TL, Meyer CR, et al. The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome. Neoplasia 2006;8(4):259-267.
5. Thoeny HC, De Keyzer F, Oyen RH, Peeters RR. Diffusion-weighted MR imaging of kidneys in healthy volunteers and patients with parenchymal diseases: initial experience. Radiology 2005;235(3):911-917. (Pubitemid 40695889)
6. Cui Y, Zhang XP, Sun YS, Tang L, Shen L. Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases. Radiology 2008;248(3):894-900.
7. Sharma U, Danishad KK, Seenu V, Jagannathan NR. Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. NMR Biomed 2009;22(1):104-113.
8. Dzik-Jurasz A, Domenig C, George M, et al. Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet 2002;360(9329):307-308. (Pubitemid 34874724)
9. Wang XZ, Wang B, Gao ZQ, et al. Diffusion-weighted imaging of prostate cancer: correlation between apparent diffusion coefficient values and tumor proliferation. J Magn Reson Imaging 2009;29(6):1360-1366.
10. Holodny AI, Makeyev S, Beattie BJ, Riad S, Blasberg RG. Apparent diffusion coefficient of glial neoplasms: correlation with fluorodeoxyglucose- positron-emission tomography and gadolinium-enhanced MR imaging. AJNR Am J Neuroradiol 2010;31(6):1042-1048.
11. Thoeny HC, Ross BD. Predicting and monitoring cancer treatment response with diffusion-weighted MRI. J Magn Reson Imaging 2010;32(1):2-16.
12. Thoeny HC. Diffusion-weighted MRI in head and neck radiology: applications in oncology. Cancer Imaging 2011;10(1):209-214.
13. Schafer J, Srinivasan A, Mukherji S. Diffusion magnetic resonance imaging in the head and neck. Magn Reson Imaging Clin N Am 2011;19(1):55-67.
14. Razek AA. Diffusion-weighted magnetic resonance imaging of head and neck. J Comput Assist Tomogr 2010;34(6):808-815.
15. Yoshino N, Yamada I, Ohbayashi N, et al. Salivary glands and lesions: evaluation of apparent diffusion coefficients with split-echo diffusion-weighted MR imaging-initial results. Radiology 2001;221(3):837-842. (Pubitemid 33101783)
16. Namimoto T, Yamashita Y, Mitsuzaki K, Nakayama Y, Tang Y, Takahashi M. Measurement of the apparent diffusion coefficient in diffuse renal disease by diffusion-weighted echo-planar MR imaging. J Magn Reson Imaging 1999;9(6):832-837. (Pubitemid 29266396)
17. Thoeny HC, De Keyzer F, Claus FG, Sunaert S, Hermans R. Gustatory stimulation changes the apparent diffusion coefficient of salivary glands: initial experience. Radiology 2005;235(2):629-634. (Pubitemid 40571107)
18. Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988;168(2):497-505.
19. Symms MR, Wheeler-Kingshott CA, Parker GJM, Barker GJ. ZOnally-magnified Oblique Multislice (ZOOM) EPI [abstr]. In: Proceedings of the Eighth Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2000; 160.
20. Wheeler-Kingshott CA, Trip SA, Symms MR, Parker GJ, Barker GJ, Miller DH. In vivo diffusion tensor imaging of the human optic nerve: pilot study in normal controls. Magn Reson Med 2006;56(2):446-451. (Pubitemid 44162793)
21. Bammer R. Basic principles of diffusion-weighted imaging. Eur J Radiol 2003;45(3):169-184. (Pubitemid 36197713)
22. Thoeny HC, De Keyzer F, Boesch C, Hermans R. Diffusion-weighted imaging of the parotid gland: Influence of the choice of b-values on the apparent diffusion coefficient value. J Magn Reson Imaging 2004;20(5):786-790. (Pubitemid 39426073)
23. Thoeny HC, Zumstein D, Simon-Zoula S, et al. Functional evaluation of transplanted kidneys with diffusion-weighted and BOLD MR imaging: initial experience. Radiology 2006;241(3):812-821. (Pubitemid 46190548)
24. Padhani AR, Liu G, Koh DM, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 2009;11(2):102-125.
25. Vandecaveye V, De Keyzer F, Vander Poorten V, et al. Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging. Radiology 2009;251(1):134-146.
26. Galbán CJ, Mukherji SK, Chenevert TL, et al. A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy. Transl Oncol 2009;2(3):184-190.
27. Wang J, Takashima S, Takayama F, et al. Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging. Radiology 2001;220(3):621-630. (Pubitemid 32799967)
28. Srinivasan A, Dvorak R, Perni K, Rohrer S, Mukherji SK. Differentiation of benign and malignant pathology in the head and neck using 3T apparent diffusion coefficient values: early experience. AJNR Am J Neuroradiol 2008;29(1):40-44.
29. Abdel Razek AA, Gaballa G, Elhawarey G, Megahed AS, Hafez M, Nada N. Characterization of pediatric head and neck masses with diffusion-weighted MR imaging. Eur Radiol 2009;19(1):201-208.
30. Venail F, Bonafe A, Poirrier V, Mondain M, Uziel A. Comparison of echo-planar diffusion-weighted imaging and delayed postcontrast T1-weighted MR imaging for the detection of residual cholesteatoma. AJNR Am J Neuroradiol 2008;29(7):1363-1368.
31. Aikele P, Kittner T, Offergeld C, Kaftan H, Hüttenbrink KB, Laniado M. Diffusion-weighted MR imaging of cholesteatoma in pediatric and adult patients who have undergone middle ear surgery. AJR Am J Roentgenol 2003;181(1):261-265. (Pubitemid 36741498)
32. Cimsit NC, Cimsit C, Baysal B, Ruhi IC, Ozbilgen S, Aksoy EA. Diffusion-weighted MR imaging in postoperative follow-up: reliability for detection of recurrent cholesteatoma. Eur J Radiol 2010;74(1):121-123.
33. Vercruysse JP, De Foer B, Pouillon M, Somers T, Casselman J, Offeciers E. The value of diffusion-weighted MR imaging in the diagnosis of primary acquired and residual cholesteatoma: a surgical verified study of 100 patients. Eur Radiol 2006;16(7):1461-1467. (Pubitemid 43871817)
34. Schwartz KM, Lane JI, Bolster BD Jr, Neff BA. The utility of diffusion-weighted imaging for cholesteatoma evaluation. AJNR Am J Neuroradiol 2011;32(3):430-436.
35. Ganaha A, Outa S, Kyuuna A, et al. Efficacy of diffusion-weighted magnetic resonance imaging in the diagnosis of middle ear cholesteatoma. Auris Nasus Larynx 2011;38(3):329-334.
36. Fitzek C, Mewes T, Fitzek S, Mentzel HJ, Hunsche S, Stoeter P. Diffusion-weighted MRI of cholesteatomas of the petrous bone. J Magn Reson Imaging 2002;15(6):636-641. (Pubitemid 34606497)
37. Dubrulle F, Souillard R, Chechin D, Vaneecloo FM, Desaulty A, Vincent C. Diffusion-weighted MR imaging sequence in the detection of postoperative recurrent cholesteatoma. Radiology 2006;238(2):604-610. (Pubitemid 43134373)
38. De Foer B, Vercruysse JP, Bernaerts A, et al. Middle ear cholesteatoma: non-echo-planar diffusion-weighted MR imaging versus delayed gadolinium-enhanced T1-weighted MR imaging-value in detection. Radiology 2010;255(3): 866-872.
39. Ikeda M, Motoori K, Hanazawa T, et al. Warthin tumor of the parotid gland: diagnostic value of MR imaging with histopathologic correlation. AJNR Am J Neuroradiol 2004;25(7):1256-1262. (Pubitemid 39095179)
40. Yabuuchi H, Matsuo Y, Kamitani T, et al. Parotid gland tumors: can addition of diffusion-weighted MR imaging to dynamic contrast-enhanced MR imaging improve diagnostic accuracy in characterization? Radiology 2008;249(3):909-916.
41. Habermann CR, Arndt C, Graessner J, et al. Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? AJNR Am J Neuroradiol 2009;30(3):591-596.
42. Habermann CR, Gossrau P, Graessner J, et al. Diffusion-weighted echo-planar MRI: a valuable tool for differentiating primary parotid gland tumors? Rofo 2005;177(7):940-945. (Pubitemid 40977363)
43. Johnson JT. A surgeon looks at cervical lymph nodes. Radiology 1990;175(3):607-610. (Pubitemid 20191910)
44. Abdel Razek AA, Soliman NY, Elkhamary S, Alsharaway MK, Tawfik A. Role of diffusion-weighted MR imaging in cervical lymphadenopathy. Eur Radiol 2006;16(7):1468-1477.
45. de Bondt RB, Hoeberigs MC, Nelemans PJ, et al. Diagnostic accuracy and additional value of diffusion-weighted imaging for discrimination of malignant cervical lymph nodes in head and neck squamous cell carcinoma. Neuroradiology 2009;51(3):183-192.
46. Holzapfel K, Duetsch S, Fauser C, Eiber M, Rummeny EJ, Gaa J. Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes. Eur J Radiol 2009;72(3):381-387.
47. Sumi M, Sakihama N, Sumi T, et al. Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer. AJNR Am J Neuroradiol 2003;24(8):1627-1634. (Pubitemid 37151732)
48. Maeda M, Kato H, Sakuma H, Maier SE, Takeda K. Usefulness of the apparent diffusion coefficient in line scan diffusion-weighted imaging for distinguishing between squamous cell carcinomas and malignant lymphomas of the head and neck. AJNR Am J Neuroradiol 2005;26(5):1186-1192. (Pubitemid 43821971)
49. King AD, Ahuja AT, Yeung DK, et al. Malignant cervical lymphadenopathy: diagnostic accuracy of diffusion-weighted MR imaging. Radiology 2007;245(3):806-813. (Pubitemid 350127351)
50. Razek AA, Sadek AG, Kombar OR, Elmahdy TE, Nada N. Role of apparent diffusion coefficient values in differentiation between malignant and benign solitary thyroid nodules. AJNR Am J Neuroradiol 2008;29(3):563-568. (Pubitemid 351424075)
51. Erdem G, Erdem T, Muammer H, et al. Diffusion-weighted images differentiate benign from malignant thyroid nodules. J Magn Reson Imaging 2010;31(1):94-100.
52. Bozgeyik Z, Coskun S, Dagli AF, Ozkan Y, Sahpaz F, Ogur E. Diffusion-weighted MR imaging of thyroid nodules. Neuroradiology 2009;51(3):193-198.
53. Kim S, Loevner L, Quon H, et al. Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res 2009;15(3):986-994.
54. Hatakenaka M, Nakamura K, Yabuuchi H, et al. Pretreatment apparent diffusion coefficient of the primary lesion correlates with local failure in head-and-neck cancer treated with chemoradiotherapy or radiotherapy. Int J Radiat Oncol Biol Phys 2011;81(2):339-345.
55. King AD, Mo FK, Yu KH, et al. Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response. Eur Radiol 2010;20(9):2213-2220.
56. Hamstra DA, Lee KC, Moffat BA, Chenevert TL, Rehemtulla A, Ross BD. Diffusion magnetic resonance imaging: an imaging treatment response biomarker to chemoradiotherapy in a mouse model of squamous cell cancer of the head and neck. Transl Oncol 2008;1(4):187-194.
57. Vandecaveye V, Dirix P, De Keyzer F, et al. Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma. Eur Radiol 2010;20(7):1703-1714.
58. Berrak S, Chawla S, Kim S, et al. Diffusion weighted imaging in predicting progression free survival in patients with squamous cell carcinomas of the head and neck treated with induction chemotherapy. Acad Radiol 2011;18(10):1225-1232.
59. Vandecaveye V, Dirix P, De Keyzer F, et al. Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2011 Apr 20. [Epub ahead of print]
60. Zbären P, Caversaccio M, Thoeny HC, Nuyens M, Curschmann J, Stauffer E. Radionecrosis or tumor recurrence after radiation of laryngeal and hypopharyngeal carcinomas. Otolaryngol Head Neck Surg 2006;135(6):838-843. (Pubitemid 44820626)
61. Abdel Razek AA, Kandeel AY, Soliman N, et al. Role of diffusion-weighted echo-planar MR imaging in differentiation of residual or recurrent head and neck tumors and post-treatment changes. AJNR Am J Neuroradiol 2007;28(6):1146-1152. (Pubitemid 46984559)
62. Vandecaveye V, De Keyzer F, Nuyts S, et al. Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings. Int J Radiat Oncol Biol Phys 2007;67(4):960-971.
63. Wong RJ. Current status of FDG-PET for head and neck cancer. J Surg Oncol 2008;97(8):649-652. (Pubitemid 351812964)
64. Sumi M, Takagi Y, Uetani M, et al. Diffusion-weighted echoplanar MR imaging of the salivary glands. AJR Am J Roentgenol 2002; 178(4):959-965. (Pubitemid 34250239)
65. Zhang L, Murata Y, Ishida R, Ohashi I, Yoshimura R, Shibuya H. Functional evaluation with intravoxel incoherent motion echo-planar MRI in irradiated salivary glands: a correlative study with salivary gland scintigraphy. J Magn Reson Imaging 2001;14(3):223-229. (Pubitemid 32801055)
66. Habermann CR, Cramer MC, Graessner J, et al. Functional imaging of parotid glands: diffusion-weighted echo-planar MRI before and after stimulation. Rofo 2004;176(10): 1385-1389. (Pubitemid 39382282)
67. Dirix P, De Keyzer F, Vandecaveye V, Stroobants S, Hermans R, Nuyts S. Diffusion-weighted magnetic resonance imaging to evaluate major salivary gland function before and after radiotherapy. Int J Radiat Oncol Biol Phys 2008;71(5):1365-1371.
68. Tezuka M, Murata Y, Ishida R, Ohashi I, Hirata Y, Shibuya H. MR imaging of the thyroid: correlation between apparent diffusion coefficient and thyroid gland scintigraphy. J Magn Reson Imaging 2003; 17(2):163-169. (Pubitemid 36151003)
69. Abdel Razek AA, Sadek AG, Gaballa G. Diffusion-weighed MR of the thyroid gland in Graves' disease: assessment of disease activity and prediction of outcome. Acad Radiol 2010;17(6):779-783.